BridgeMD
New treatment option for Feeding and Eating Disorders
Official title Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System
ClinicalTrials.gov ID: NCT06057415
What this study is testing
- What it's testing
- The goal of this therapeutical intervention trial is to investigate whether tactile-kinesthaetic and oral sensorimotor stimulation can improve gastrointestional function in preterm infants born before gestational age of 30 weeks and newborns with congenital diaphragmatic hernia. The main question it aims to answer is: To determine whether HAPTOS- intervention (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation) in the particpants results in earlier attainment (postnatal days) of full enteral feeding and/or full oral feeding (post menstrual age) compared to standard care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 2
You may be able to join if
- Preterm birth at gestational age \< 30 weeks or
- Diagnosis of Congenital Diaphragmatic Hernia
- Born at Amalia Children's Hospital or admitted 1rst day of life
- Written informed consent of both parents or representatives
You likely can't join if
- Preterm infant born at gestational age ≥ 30 weeks
- Perinatal Asphyxia; (Apgar score at 5' \< 5 and first pH ≤ 7,0)
- Major congenital anomalies or birth defects other than congenital diaphragmatic hernia;
- Metabolic disease that necessitates a special diet other than human milk or formula feeding and or has a prognosis of impaired neurological...
- Parental refusal of participation
The study team makes the final eligibility decision.
Where it's taking place
- Nijmegen, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 2 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nijmegen, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.